Methods of treating depression and anxiety
AssigneeWoolsey Pharmaceuticals, Inc.
InventorsThomas MACALLISTER, Sven JACOBSON
Life of this patent
Estimating the term…
Abstract
The invention relates to the treatment of patients with depression and or anxiety with low doses of rho kinase inhibitors. The maximum dose of a rho kinase inhibitor, based on fasudil hydrochloride as an exemplary agent, is less than 60 mg per day based on an immediate release formulation. Comparable dosing with other inhibitors is selected based on molar equivalents and/or rho kinase binding affinities. Treatable patients have one or more depressive disorders and/or one or more anxiety disorders.
Claims12
A method of treating a patient suffering from a depression disorder, an anxiety disorder, or both, comprising administering a therapeutically effective amount of a rho kinase inhibitor to said patient.
Dependencies are inferred from the claim text.